Trial
NCT02484703
A Study of RO5186582 in Down Syndrome Among Children 6 to 11 Years of Age
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Hoffmann-La Roche
Collaborators
—
Condition
Down Syndrome
Intervention
Placebo
Why stopped
Study was terminated due to data from another study showing no efficacy. There were no safety issues of concern.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-07-06